INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 188 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 750 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 750 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 750 | -28.6% | 0.00% | – |
| Q4 2021 | $5,000 | -85.3% | 1,050 | -78.1% | 0.00% | – |
| Q3 2021 | $34,000 | -22.7% | 4,800 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -2.2% | 4,800 | -1.6% | 0.00% | – |
| Q1 2021 | $45,000 | -2.2% | 4,878 | -7.1% | 0.00% | – |
| Q4 2020 | $46,000 | +24.3% | 5,250 | +61.5% | 0.00% | – |
| Q3 2020 | $37,000 | -80.4% | 3,250 | -53.6% | 0.00% | -100.0% |
| Q2 2020 | $189,000 | +894.7% | 7,000 | +169.2% | 0.00% | – |
| Q1 2020 | $19,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |